A multi-agency drive by the US Food and Drug Administration, the Federal Trade Commission and equivalent governmental departments in neighboring Canada and Mexico has been launched to stop the fraudulent or misleading promotion of diabetes remedies that are sold over the Internet.
"Be smart, be skeptical" on-line
Lydia Parnes, Director of the FTC's Bureau of Consumer Protection, in a statement, said: "the Internet can be a great source of information, but it also is a billboard for ads that promise miracle cures for diabetes and other serious diseases. Our advice to consumers: 'Be smart, be skeptical' when evaluating health claims on-line."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze